Aurobindo Pharma Slapped With Rs 11 Crore GST Demand, Plans Appeal

Hyderabad: Aurobindo Pharma has been hit with a Rs 11 crore GST demand by Andhra Pradesh authorities, accusing the company of overstating its Input Tax Credit (ITC) for the financial years 2017-18 to 2019-20, along with interest.

The Additional Commissioner (ST), Appellate Authority, Vijayawada, Andhra Pradesh, has sent a notice to the drugmaker demanding the reversal of Input Tax Credit (ITC) and payment of Goods and Services Tax (GST) for the financial years 2017-18 to 2019-20. The total amount in dispute stands at Rs 11.05 crore, including the reversal of ITC amounting to Rs. 5.68 crore, interest of Rs. 4.79 crore, and a penalty of Rs. 56.86 lakh.

The order, passed under the provisions of the Central Goods and Services Tax Act, 2017 and the Andhra Pradesh Goods and Services Tax Act, 2017, alleges that Aurobindo Pharma had claimed excess ITC compared to the GSTR 2A filings and made claims on supplies received from non-filers of GSTR 3B. The company intends to file an appeal before the Tribunal to challenge the decision.

In a statement, Aurobindo Pharma assured investors that the order would not have a material impact on its financials or operations. The company has disclosed the details of the order in accordance with SEBI’s (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Despite the ongoing legal proceedings, the company stated that it does not expect any significant financial or operational disruption from the order. The company plans to challenge the order by filing an appeal with the Tribunal.

Aurobindo Pharma, a global pharmaceutical player based in Hyderabad, is involved in the production and distribution of generic medicines, including those for key therapeutic segments such as anti-retroviral, antibiotics, and central nervous system disorders.

Powered by WPeMatico

Violence at Mayaganj Hospital: Mob attacks On-Duty doctor, hospital staff; throws fire extinguisher

Bhagalpur: Violence erupted at Jawaharlal Nehru Medical College and Hospital (JLNMCH), also known as Mayaganj Hospital where an on-duty doctor suffered serious head injuries after a fire extinguisher cylinder was thrown at him by relatives after an injured patient was declared dead upon arrival. Eight more people sustained injuries during the altercation.  

The injured individuals in the violent altercation included two doctors, hospital staff and police personnel who reached the spot to control the situation. The incident began at 10:18 PM on Friday when the patient, a resident of Makandpur, succumbed to his injuries following a road accident. As soon as doctors informed the family of his death, they allegedly attacked the medical staff.

Also read- Viral Video of nursing staff dancing during Christmas celebration at Telangana Hospital draws inquiry

According to a Hindustan news report, the family threw a fire extinguisher cylinder at one of the on-duty doctors, which hit his head causing serious injuries. Apart from him, another doctor was also injured in the altercation.

Hospital guards and police officers who were trying to manage the situation were also attacked and sustained injuries. Two inspectors who came to calm the matter were also beaten up.

The deceased’s son-in-law told the Daily, that he had gone to Sangrampur with his father-in-law to see a girl for his brother-in-law. After seeing the girl, he was returning with his father-in-law on the bike however, both met with an accident between Shahkund and Akbarnagar. They were brought to a hospital in Shahkund but later referred to Mayaganj Hospital.

The doctors at Mayaganj Hospital declared him brought dead considering his situation. This led to a ruckus at the campus and escalated to a violent altercation with doctors and hospital staff getting injured.

The angry family members accused the ambulance staff of negligence, claiming that while oxygen was administered to the man, the supply was not turned on. Moreover, they also vandalised the hospital property and the medical equipment in a rage.

To control the situation, Hospital Superintendent Dr. K.K. Sinha, along with SDM Sadar Dhananjay Kumar and DSP City-1 Ajay Chaudhary, rushed to the scene. The hospital management confirmed that an official complaint would be filed, and authorities plan to use CCTV footage to identify the attackers. 

Meanwhile, as per the Daily, the CCTV footage suggests that around 10 individuals were involved in the assault, however, some hospital staff alleged that the group consisted of 30 individuals. 

Also read- Private hospital staff arrested after female patient alleges sexual harassment

Powered by WPeMatico

Maharashtra Medical Council to take strict action against doctors over misleading ads, misuse of social media

The Maharashtra Medical Council (MMC) has decided to take strict action against doctors for misleading advertisements and misuse of social media by registered medical practitioners.

The medical council is to start taking action against doctors after receiving complaints from patients in this regard. The Council has received seven such complaints against registered medical practitioners.

For more information, click on the link below:

Powered by WPeMatico

HC slams State for arbitrary action, says doctors deserve rightful pay

Upholding a single judge bench’s order of granting assistant professors their due pay scales in accordance with the Punjab Medical Education (Group-A) Service Rules of 2016, the Punjab and Haryana High Court recently held that doctors deserve respect and their rightful pay under the law.

Before dismissing an appeal filed by Assistant Professors, the HC Division bench of Justices Anupinder Singh Grewal and Lapita Banerji also slammed the State Government for its capricious and irrational action, The Tribune has reported.

For more information, click on the link below:

Powered by WPeMatico

Indian Pharma Market Posts Robust 10.7% Growth in November, Foracort Tops Sales: IQVIA

New Delhi: The Indian pharmaceutical market displayed a strong recovery in November 2024, with robust growth across key therapeutic areas, including dermatology, respiratory treatments, cardiac care, and pain management. According to IQVIA’s latest Market Reflection Report, the Total Sales Audit (TSA) for the Indian Pharmaceutical Market (IPM) reached Rs 19,926 crore for the month, reflecting a 10.7% year-on-year growth. Similarly, the Secondary Sales Audit (SSA) stood at Rs 16,903 crore, registering a 10.8% increase compared to the same period last year.

Top Performers in November 2024

Leading the market, Foracort—a respiratory drug widely used for asthma—secured the top position among brands with sales of Rs 82 crore and a market share of 0.41%, achieving a 2% monthly growth. Augmentin, an antibiotic, followed with Rs 76 crore in sales, marking a 9% rise, while anti-diabetic therapy Glycomet GP remained steady with Rs 69 crore in sales.

Other standout brands included Zerodol SP, which grew by 22%, and Rybelsus, a diabetes medication, which recorded a staggering 75% growth, advancing eight ranks to secure a spot among the top 25 brands. Cilacar showed a 26% increase, climbing two ranks, while Budecort and Azithral rose by 10 ranks each, underscoring growing demand in their respective categories.

Therapeutic Categories Fueling Growth

Key therapeutic areas were instrumental in driving the market’s recovery in November. Urology topped the charts with an 18% growth, reflecting increased demand for treatments in this segment. Dermatology followed closely, growing by 16%, bolstered by heightened sales of emollients (21%) and sunscreens (24%). Cardiac and pain-relief medications each posted a 13% increase, supported by innovative therapies like Sacubitril + Valsartan (26% growth in cardiac) and paracetamol-based formulations in pain management.

Respiratory therapies benefited significantly from worsening air pollution across the country, with medications like Foracort and Budecort addressing heightened patient needs. Acute therapies for short-term conditions like infections and chronic therapies for long-term ailments such as diabetes and cardiovascular diseases both recorded an 11% growth.

Subgroup Contributions to Therapy Areas

In respiratory therapy, Cold Preparation Ethicals emerged as the highest-contributing subgroup, achieving sales of Rs 265 crore. In the pain market, paracetamol oral solids, injections, and liquids collectively generated Rs 189 crore, with respective growth rates of 2%, 29%, and 6%.

The Vitamins, Minerals, and Nutrients (VMN) segment recorded strong growth, with food supplements contributing Rs 239 crore and posting a 16% increase. Dermatology also witnessed impressive numbers, with emollients and protectives generating Rs 197 crore in sales, while sunscreens exhibited the highest growth at 24%.

Among other noteworthy performances, the gastrointestinal segment was led by Esomeprazole + Domperidone, which posted a growth of 32%. Antineoplastic therapies saw Cetuximab achieving the highest growth at 53%, while Glimepiride + Metformin registered Rs 292 crore in anti-diabetic sales, growing by 6%.

Market Dynamics and Key Players

Sun Pharma maintained its leadership position in the Indian pharmaceutical market with an 8% market share. Other prominent players, including Cipla and Dr. Reddy’s Laboratories, strengthened their foothold with month-on-month market share gains. Multinational corporations such as Pfizer and Sanofi also climbed the rankings, benefiting from new product launches and strategic expansions.

Indian pharmaceutical companies outpaced their multinational counterparts in growth, registering a 10.8% increase compared to the MNCs’ 10.2%.

New Product Introductions and Strategic Moves

November saw the addition of 746 new stock-keeping units (SKUs), highlighting the market’s emphasis on innovation and addressing unmet patient needs. Dynamic pricing strategies were evident, with 3,024 SKUs undergoing Price to Retailer (PTR) changes. Prominent brands like Foracort, Duolin, and Betadine featured among those reflecting price revisions.

Significant brand transfers also took place, with 248 products transitioning from Bharat Serum to Mankind and 62 brands moving from Jupiter to Jupiter Biolabs, signaling strategic shifts within the competitive landscape.

Powered by WPeMatico

Allahabad HC orders State to upgrade medical facilities for children with disabilities

In a landmark ruling, the Allahabad High Court directed the state government to develop appropriate educational and medical facilities, along with other support systems, across all districts of the state to ensure the holistic development of children with disabilities.

The order was passed by Justice Ajay Bhanot, followed a petition filed by Shivani, a teacher at a government school in Etah, who sought a transfer to a school in Noida or Ghaziabad on humanitarian grounds.

For more information, click on the link below:

Powered by WPeMatico

Health Bulletin 14/ December/ 2024

Here are the top health news for the day:

Maharashtra Medical Council to take strict action against doctors over misleading ads, misuse of social media
The Maharashtra Medical Council (MMC) has decided to take strict action against doctors for misleading advertisements and misuse of social media by registered medical practitioners.

The medical council is to start taking action against doctors after receiving complaints from patients in this regard. The Council has received seven such complaints against registered medical practitioners.

For more information, click on the link below:

HC slams State for arbitrary action, says doctors deserve rightful pay

Upholding a single judge bench’s order of granting assistant professors their due pay scales in accordance with the Punjab Medical Education (Group-A) Service Rules of 2016, the Punjab and Haryana High Court recently held that doctors deserve respect and their rightful pay under the law.

Before dismissing an appeal filed by Assistant Professors, the HC Division bench of Justices Anupinder Singh Grewal and Lapita Banerji also slammed the State Government for its capricious and irrational action, The Tribune has reported.

For more information, click on the link below:

Court grants bail to ex-RG Kar principal Sandip Ghosh 
The Sealdah court in Kolkata on Friday granted bail to Sandip Ghosh, the former principal of RG Kar Medical College and Hospital, and Abhijit Mondal, the former officer-in-charge of Tala police station, in connection with the rape and murder case of a woman trainee doctor on August 9.

While Mondal was accused of alleged delay in filing of FIR in the rape and murder of the on-duty doctor at R G Kar Hospital on August 9, Sandip Ghosh was accused of tampering with evidence in the case.

For more information, click on the link below:

Allahabad HC orders State to upgrade medical facilities for children with disabilities

In a landmark ruling, the Allahabad High Court directed the state government to develop appropriate educational and medical facilities, along with other support systems, across all districts of the state to ensure the holistic development of children with disabilities.

The order was passed by Justice Ajay Bhanot, followed a petition filed by Shivani, a teacher at a government school in Etah, who sought a transfer to a school in Noida or Ghaziabad on humanitarian grounds.

For more information, click on the link below:

Powered by WPeMatico

Court grants bail to ex-RG Kar principal Sandip Ghosh

The Sealdah court in Kolkata on Friday granted bail to Sandip Ghosh, the former principal of RG Kar Medical College and Hospital, and Abhijit Mondal, the former officer-in-charge of Tala police station, in connection with the rape and murder case of a woman trainee doctor on August 9.

While Mondal was accused of alleged delay in filing of FIR in the rape and murder of the on-duty doctor at R G Kar Hospital on August 9, Sandip Ghosh was accused of tampering with evidence in the case.

For more information, click on the link below:

Powered by WPeMatico

India has 1.18 crores Hepatitis B cases: MoS Health informs Rajya Sabha

New Delhi: The Ministry of Health and Family Welfare informed that the WHO Global Hepatitis Report 2024 is based on modelling rather than actual surveillance figures. Viral hepatitis, particularly hepatitis B and C, is a major public health issue worldwide. The WHO Global Hepatitis Report 2024 indicates that India accounts for a significant proportion of the global burden of hepatitis, especially hepatitis B. 

India has recognized the serious public health threat of viral hepatitis and has taken major steps to address the issue through the National Viral Hepatitis Control Program (NVHCP).

Also Read: Rs 7528.93 lakhs allocated for Telemedicine Network, says MoS Health

The Minister of State for Health Smt. Anupriya Patel was responding to questions posed by Shri Akhilesh Prasad Singh during the Rajya Sabha Session about whether, as per the WHO Global Hepatitis Report 2024, India has the world’s second-highest prevalence of viral hepatitis cases with 2.9 crore hepatitis B cases, if so, the reasons therefor;

He also asked whether the low diagnosis and treatment are major causes for the high number of cases; if not, the other causes;

He further inquired whether all the hepatitis-infected people were receiving free treatment for the disease; if not, whether the Government will provide free treatment to hepatitis patients under the National Viral Hepatitis Control Programme (NVHCP); and, if not, about the reasons. 

Also Read: No conclusive data available to establish correlation of disease due to air pollution: MoS Health tells Lok Sabha

MoS Health informed that no, the data of WHO Global Health Report 2024 is based on modeling and is not the actual surveillance data. As per the 2023 Seroprevalence report generated under the National Program for Surveillance of Viral Hepatitis under the National Viral Hepatitis Control Program (NVHCP), National Health Mission (NHM.), the seroprevalence of hepatitis B is found to be 0.85% (95% CI 0.85-0.86). Accordingly, the estimated number of persons likely to be infected with hepatitis B is 1.18 crores.

The National Viral Hepatitis Control Program (NVHCP) was launched in 2018 and is offering treatment services for hepatitis B since 2019. The government provides diagnosis and treatment of hepatitis B free of cost under the program on the basis of the requirements of the need of an infested patient under treatment, added the Minister.

Powered by WPeMatico

234 SR Post Vacancies: VMMC, Safdarjung Hospital Delhi, Check Walk In Interview Details

New Delhi: The Safdarjung Hospital and Vardhman Mahavir Medical College (VMMC), New Delhi have announced vacancies for the post of Senior Resident on an ad hoc basis in various hospital departments. The selection will be based on the interview. 

Safdarjung Hospital was founded in 1942 during the Second World War as a Base Hospital for the allied forces. It was taken over by the Govt. of India in 1954 under the Ministry of Health. It has grown over the years into one of the largest, tertiary, level multi-disciplinary healthcare institutions in this part of the World. Based on the needs and developments in Medical Care, the hospital has regularly upgraded its facilities from diagnostic and therapeutic aspects to all the specialties.

VMMC Vacancy Details:

Total no of Vacancies: 233

The Vacancies are in the Departments of Anaesthesia, Anatomy, Bio-Chemistry, Cancer Surgery, Cardiology, Community Medicine, Critical Care Medicine, CTVS, Dermatology, Emergency Medicine, Endocrinology, ENT, Forensic Medicine, Hematology, Lab Oncology, Medical Oncology, Medicine, Microbiology, Nephrology, Neuro Surgery, Neurology, Nuclear Medicine, Obstetrics and Gynaecology, Ophthalmology, Orthopedics, Pediatrics, Paediatrics Surgery, Pathology, Pharmacology, Physiology, Physical Medicine Rehabilitation, Psychiatry, Pulmonary Medicine, Radiology, Radiotherapy, Renal Transplant, SIC Ortho, SIC Rhab, and Surgery.

The date of walk-in-interview is 16th, 17th, and 18th, December 2024.

Venue and Reporting time:- from 09.00 A.M. to 11 A.M. in the Committee Room, MS Office in Academic Section, Room no.14, New Delhi-110029.

For more details about Qualifications, Age, Pay Allowance, and much more, click on the given link:
https://medicaljob.in/jobs.php?post_type=&job_tags=Safdarjung+Hospital&location=&job_sector=all

How to Apply For Eligible Candidates?

1. Eligible candidates will present themselves for registration on date of walk-in-interview as per time of reporting mentioned below in the table in Academic Section, Room no.14, Ground Floor, VMMC Building. They must bring original certificate/documents at the time of registration along with one set of self-attested copies of all documents in support of their candidature for the post and one recent passport size photograph & duly filled Application Form as per Annexure-I.

2. Undertaking in application form must be signed by the candidate.

3. Crucial date for determination of eligibility with reference to age, educational qualification and experience etc. will be the date of walk-in-interview.

4. The appointment will be initially for a period of 89 days, which could be extended for a further period of 89 days, subject to the satisfactory work & conduct report from the concerned HOD. The maximum tenure of Senior Resident will be three years including any service rendered earlier as Senior Resident on adhoc/regular basis in any Govt. of India/State Government hospital/institution.

5. Other service conditions will be applicable as per service conditions prescribed from time to time by the Govt. of India.

6. The candidate who is already employed should submit No Objection Certificate from present employer. Relieving is required from the present employer before joining.

7. Inter – hospital/Institution transfer shall not be permitted.

8. The candidate must bring following original certificates at the time of interview

a. Certificate in support of age (10th certificate)

b. Registration with DMC/DDC for both MBBS/BDS and PG.

c. MBBS degree/provisional pass Certificate.

d. MD/MS/DNB/Diploma Degree/provisional Pass Certificate.

e. SC/ ST/OBC Caste certificate in the prescribed format by Govt. of India.

f. EWS candidates to submit copy of Income & Asset Certificate as per AnnexureIII having date of issue on or after 01.04.2024 (valid for year 2024-25) vide OM No. 36039/1/2019-Estt (Res) dated 31.01.2019 of DOPT, Ministry of Personal & Public Grievance & Pensions, New Delhi.

g. EWS candidate must bring copy of Form 16 for financial year 2023-24, if he/she was working during that period h. Experience certificate, if any.

i. No Objection Certificate, if employed in Central Govt / State Govt / PSUs / Autonomous Bodies. **Candidate must submit the latest OBC certificate issued on or after 01-04-2024 by the competent authority in the format prescribed by DOPT, Govt. of India for appointment to Central Government posts (as per Annexure-II).

9. Result will be published within 03 days and tentative date of joining will be 07 days (approx.) from the date of issue of the result. Further extension for joining will not be granted.

10. The candidate has to collect his/her offer of appointment from Academic Section after display of final result. The offer of appointment shall stand cancelled, if acceptance to the post is not received within the stipulated time period.

11. Application form as per Annexure-I can be downloaded from the official website (www.vmmc-sjh.mohfw.gov.in).

12. Candidates are advised to visit official website (www.vmmc-sjh.mohfw.gov.in) at regular interval for all further notifications incl. final result.

Also Read:Walk In Interview For SR Post At ESIC Medical College And Hospital Bengaluru, Apply Now

Powered by WPeMatico